Blaze Bio Raises $5M to Help Surgeons See Tumors From Healthy Tissue

Blaze Bioscience, a Seattle-based biotech developing “tumor paint” that could help surgeons tell the difference between normal and cancerous tissue, has raised $5 million in new equity funding to help advance its lead product candidate through clinical trials.